2 out of 3 babies get RSV by age 1
That's why there's Beyfortus® (nirsevimab-alip) 50 mg and 100 mg injection
Beyfortus is a prescription medicine used to help prevent a serious lung disease caused by Respiratory Syncytial Virus (RSV) in:
- Newborns and babies under 1 year of age born during or entering their first RSV season.
- Children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season.
Babies are 16x more likely to be hospitalized with serious RSV lung infection than the flu
Most of the time RSV will cause a mild, cold-like illness. And while serious RSV lung infection is rare, it can lead to hospitalization. The best time to learn about RSV is now.
Learn More About RSV
An extra layer of protection against serious lung infection caused by RSV
Beyfortus gives babies fast-acting protection to help prevent serious RSV lung infections like pneumonia.
Learn More About BeyfortusBeyfortus is recommended by the American Academy of Pediatrics (AAP)
Is my baby eligible to get Beyfortus at no cost?
Beyfortus is part of the approved immunization schedule for babies and is covered by the Vaccines for Children (VFC) program and many private health insurance plans.
Explore Cost & Coverage